Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus, European Journal of Gastroenterology & Hepatology, December 1998, Wolters Kluwer Health,
DOI: 10.1097/00042737-199812000-00020.
You can read the full text:
Contributors
The following have contributed to this page
